SARS-CoV-2-derived RNA replicons as safe and effective vaccines - Marta Villarejo-Torres; Iván Nombela-Diaz; Diego Muñóz-Santos; Mercedes Ruiz-Yuste; Ana Marchena-Pasero; María A. Rueda-Huélamo; Jorge Ripoll-Gómez; Pedro J. Sánchez-Cordón; Laura Fernandez del Ama; José M. Honrubia; Javier Gutiérrez-Álvarez; Jesús Hurtado-Tamayo; et al. (Proceedings of the National Academy of Sciences, 2025)